Hand Osteoarthritis Clinical Trial
Official title:
Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis: Study Protocol for a Randomized Controlled Trial
Hand osteoarthritis (OA) is a prevalent joint disorder characterized by pain, stiffness, and
bony enlargements/swellings of multiple joints, in particular distal interphalangeal (DIP),
proximal interphalangeal (PIP) and first carpometacarpal (CMC) joints. Symptomatic hand OA is
estimated to affecting 15.9% of women and 8.2% of men in the general population with a
variable disease course, occurring more frequently in the elderly. Many factors including
age, gender, obesity, genetic predisposition, joint deformity, joint hypermobility, and
trauma are implicated in the development of hand OA. In addition to pain and stiffness,
patients with hand OA often suffer from the reduced grip and pinch strength, decreased range
of motion in involved and noninvolved joints, and difficulty performing dexterous tasks,
resulting in disability in activities of daily living and considerable frustration.
At present, no therapies can completely cure hand OA and few therapeutic options with proven
effectiveness for hand OA exist. Diclofenac sodium gel (DSG) is one of the commonly used
topical NSAIDs, which can provide local pain relief for patients with hand OA with reduced
systemic exposure, potentially reducing the risk of adverse events (AE). Acupuncture is
effective in a host of pain-related conditions, ranging from low back pain, neck pain,
shoulder pain, migraine to pain from knee OA. The research on the effects of acupuncture in
people with hand OA is very limited.
The purpose of this study is to investigate the clinical effectiveness of 4-week
electroacupuncture(EA) compared to topical DSG in the treatment of hand OA. Our primary
hypothesis was that EA would result in a greater pain relief improvement in hand OA compared
with topical DSG.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01910116 -
Efficacy of Shinabro in Hand Osteoarthritis
|
Phase 2/Phase 3 | |
Completed |
NCT02612233 -
Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin
|
Phase 4 | |
Completed |
NCT01249391 -
Splinting to Treat Hand Osteoarthritis
|
Phase 2 | |
Completed |
NCT03911570 -
Crystalline Glucosamine Sulfate Therapy in Hand Osteoarthritis
|
||
Completed |
NCT04576403 -
Heated Mittens for Patients With Hand Osteoarthritis
|
N/A | |
Completed |
NCT02528630 -
Progressive Strength in Hand Osteoarthritis
|
Phase 4 | |
Completed |
NCT01874067 -
C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
|
||
Suspended |
NCT03703934 -
Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
|
||
Completed |
NCT04585113 -
Diagnostic Accuracy of Dual-energy CT
|
||
Completed |
NCT05568875 -
Happy Hands - an E-self-management Intervention for People With Hand Osteoarthritis
|
N/A | |
Completed |
NCT03693833 -
CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
|
Phase 2 | |
Completed |
NCT05150171 -
Happy Hands E-self-management Pilot Study
|
N/A | |
Completed |
NCT02667145 -
Assistive Device for Hand Osteoarthritis
|
N/A | |
Completed |
NCT02477059 -
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
|
Phase 3 | |
Recruiting |
NCT04611347 -
Topical CBD in Joint Arthritis
|
Phase 2 | |
Completed |
NCT04036929 -
Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?
|
N/A | |
Completed |
NCT03919279 -
Treatment of Erosive Digital Osteoarthritis by Transcutaneous Auricular Nerve Stimulation
|
N/A | |
Recruiting |
NCT06329219 -
Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis
|
N/A | |
Not yet recruiting |
NCT05216757 -
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
|
Phase 2/Phase 3 | |
Completed |
NCT02771860 -
RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints
|
Phase 2 |